by The global point-of-care biosensors market size accounted for US$ 71.24 Bn in 2022 and is projected to reach around USD 159.01 Bn by 2032, growing at a CAGR of 8.36% from 2023 to 2032.
Report Summary
The global point-of-care biosensors market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the point-of-care biosensors market across the globe.
A comprehensive estimate on the point-of-care biosensors market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of point-of-care biosensors during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2885
Point-of-care Biosensors Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 77.2 Billion |
| Market Size by 2032 | USD 159.01 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 8.36% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product, By Platforms, By Purchase, By Sample, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized point-of-care biosensors market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Military Drones Market Size To Cross USD 28.84 Bn By 2032
Point-of-care Biosensors Market Players
The report includes the profiles of key point-of-care biosensors market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area
- Abaxis
- Abbott Laboratories
- Accubiotech Co, Ltd.
- ACON Laboratories, Inc
- Becton, Dickinson and Company
- Biolytical Laboratories
- Danaher Corporation (HemoCue)
- Siemens Healthineers
- Meridian Bioscience, Inc
Market Segmentation
By Product
- Glucose Monitoring
- HIV
- Hepatitis C
- Pregnancy
By Platforms
- Microfluidics
- Dipsticks
- Immunoassays
By Purchase
- OTC
- Prescription
By Sample
- Blood
- Urine
By End User
- Pharmacy
- Hospital
- Homecare
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Point-of-care Biosensors Market
5.1. COVID-19 Landscape: Point-of-care Biosensors Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Point-of-care Biosensors Market, By Product
8.1. Point-of-care Biosensors Market Revenue and Volume, by Product, 2023-2032
8.1.1. Glucose Monitoring
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. HIV
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Hepatitis C
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
8.1.4. Pregnancy
8.1.4.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Point-of-care Biosensors Market, By Platforms
9.1. Point-of-care Biosensors Market Revenue and Volume, by Platforms, 2023-2032
9.1.1. Microfluidics
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Dipsticks
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
9.1.3. Immunoassays
9.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Point-of-care Biosensors Market, By Purchase
10.1. Point-of-care Biosensors Market Revenue and Volume, by Purchase, 2023-2032
10.1.1. OTC
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Prescription
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Point-of-care Biosensors Market, By Sample
11.1. Point-of-care Biosensors Market Revenue and Volume, by Sample, 2023-2032
11.1.1. Blood
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Urine
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global Point-of-care Biosensors Market, By End User
12.1. Point-of-care Biosensors Market Revenue and Volume, by End User, 2023-2032
12.1.1. Pharmacy
12.1.1.1. Market Revenue and Volume Forecast (2020-2032)
12.1.2. Hospital
12.1.2.1. Market Revenue and Volume Forecast (2020-2032)
12.1.3. Homecare
12.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 13. Global Point-of-care Biosensors Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.1.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.1.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.1.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.1.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.1.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.1.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.1.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.1.6.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.1.7.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.1.7.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.1.7.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.1.7.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.2.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.2.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.2.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.2.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.2.7. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.2.8. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.9.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.2.9.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.2.10. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.2.11. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.12.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.2.12.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.2.12.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.2.13. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.14.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.2.14.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.2.14.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.2.15. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.3.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.3.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.3.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.3.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.3.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.3.7. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.8.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.3.8.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.3.8.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.3.9. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.10.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.3.10.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.3.10.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.3.10.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.11.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.3.11.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.3.11.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.3.11.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.4.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.4.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.4.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.4.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.4.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.4.7. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.8.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.4.8.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.4.8.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.4.9. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.10.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.4.10.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.4.10.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.4.10.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.11.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.4.11.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.4.11.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.4.11.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.5.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.5.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.5.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.5.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.5.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.5.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.5.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.5.7. Market Revenue and Volume Forecast, by End User (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.5.8.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.5.8.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.5.8.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.5.8.5. Market Revenue and Volume Forecast, by End User (2020-2032)
Chapter 14. Company Profiles
14.1. Abaxis
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Abbott Laboratories
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Accubiotech Co, Ltd.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. ACON Laboratories, Inc
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Becton, Dickinson and Company
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Biolytical Laboratories
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Danaher Corporation (HemoCue)
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Siemens Healthineers
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Meridian Bioscience, Inc
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
